PhaseBio Pharmaceuticals News - PHAS

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
PhaseBio Pharmaceuticals Inc PHAS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 3.06 0.00 0.00 0.00 3.06 04:00:00
more quote information »

Recent News

Date Time Source Heading
4/07/20207:22IHNWFeaturedYield Growth Receives Health Canada Approval for 2nd Hand Sanitizer in Fight Against Coronavirus
3/30/202008:30EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/30/202008:21EDGARAnnual Report (10-k)
3/30/202008:09EDGARCurrent Report Filing (8-k)
3/30/202008:01GLOBEPhaseBio Reports Fourth Quarter and Full-Year 2019 Financial..
3/20/202016:13EDGARCurrent Report Filing (8-k)
3/04/202016:07EDGARCurrent Report Filing (8-k)
2/26/202016:01GLOBEPhaseBio to Present at Cowen and Company 40th Annual Health..
2/14/202018:56EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:56EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:56EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:55EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:55EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:55EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:54EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:54EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:48EDGARInitial Statement of Beneficial Ownership (3)
2/14/202018:43EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:39EDGARInitial Statement of Beneficial Ownership (3)
2/14/202013:53EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202016:09EDGARCurrent Report Filing (8-k)
2/13/202016:01GLOBEPhaseBio Appoints Alex C. Sapir to Board of Directors
2/11/202008:08EDGARCurrent Report Filing (8-k)
2/11/202008:00GLOBEPhaseBio Announces European Regulatory Update for PB2452
2/04/202016:09EDGARCurrent Report Filing (8-k)
2/04/202016:01GLOBEPhaseBio Announces Case Study Highlighting PB1046..
1/27/202015:37EDGARSchedule 13g
1/17/202013:58EDGARAmended Statement of Ownership (sc 13g/a)
1/13/202016:08EDGARCurrent Report Filing (8-k)
1/13/202016:01GLOBEPhaseBio Announces Acquisition of Novel Oral Aldosterone..
1/10/202009:08EDGARCurrent Report Filing (8-k)
1/10/202009:00GLOBEPhaseBio Announces Financing and Co-Development..
1/09/202006:01EDGARNotice of Effectiveness (effect)
12/27/201917:29EDGARSecurities Registration Statement (simplified Form) (s-3)
11/15/201908:00GLOBEPhaseBio to Present at Stifel 2019 Healthcare Conference
11/14/201908:17EDGARQuarterly Report (10-q)
11/14/201908:17EDGARCurrent Report Filing (8-k)
11/14/201908:00GLOBEPhaseBio Reports Third Quarter 2019 Financial Results and..
11/07/201916:01GLOBEPhaseBio To Report Third Quarter 2019 Financial Results and..
10/24/201916:01GLOBEPhaseBio Expands Executive Management Team
10/15/201908:04EDGARCurrent Report Filing (8-k)
10/15/201908:00GLOBEPhaseBio Announces First Patient Dosed in Phase 2b Clinical..
10/07/201919:12EDGARStatement of Changes in Beneficial Ownership (4)
10/07/201919:08EDGARInitial Statement of Beneficial Ownership (3)
9/24/201916:06EDGARCurrent Report Filing (8-k)
9/24/201916:01GLOBEPhaseBio Announces Completion of Phase 2a Clinical Trial of..
9/10/201916:11EDGARStatement of Changes in Beneficial Ownership (4)
9/03/201908:00GLOBEPharmacodynamics Evaluation of PhaseBio’s Novel Ticagrelor..
8/26/201908:00GLOBEPhaseBio Announces Presentation of PB2452 Data at ESC..
8/22/201919:43EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201909:08EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
PHAS
PhaseBio P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.